Chlamydia Trachomatis infections: Screening, diagnosis, and management

American Family Physician

Volumn 86, Issue 12, 2012, Pages 1127-1132

  Mishori, Ranit ^a   McClaskey, Erica L ^a   Winklerprins, Vince J ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; LEVOFLOXACIN; OFLOXACIN; RIFAMPICIN;

ARTICLE; ASYMPTOMATIC INFECTION; CHLAMYDIASIS; CONJUNCTIVITIS; ECTOPIC PREGNANCY; EPIDIDYMITIS; EYE INFECTION; GASTROINTESTINAL DISEASE; HUMAN; INFERTILITY; LUNG INFECTION; LYMPHOGRANULOMA VENEREUM; NEWBORN OPHTHALMIA; ORCHITIS; PELVIC INFLAMMATORY DISEASE; PNEUMONIA; REACTIVE ARTHRITIS; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; TRACHOMA; URINARY TRACT INFECTION;

EID: 84872976287     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Workowski KA, Berman S; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010 [published correction appears in MMWR Recomm Rep. 2011;60(1):18]. MMWR Recomm Rep. 2010;59 (RR-12):1-110.
2. Hu VH, Harding-Esch EM, Burton MJ, Bailey RL, Kadimpeul J, Mabey DC. Epidemiology and control of trachoma: systematic review. Trop Med Int Health. 2010;15(6):673-691.
3. Centers for Disease Control and Prevention. STD trends in the United States: 2010 national data for gonorrhea, chlamydia, and syphilis. Snapshot: sexually transmitted diseases in 2010. http://www.cdc.gov/std/stats10/tables/trends-snapshot.htm. Accessed May 21, 2012.
4. Centers for Disease Control and Prevention. Chlamydia - CDC fact sheet. http://www.cdc.gov/std/chlamydia/stdfact-chlamydia.htm. Accessed May 21, 2012.
5. Centers for Disease Control and Prevention. STD trends in the United States: 2010 national data for gonorrhea, chlamydia, and syphilis. Table. http://www.cdc.gov/std/stats10/tables/trends-table.htm. Accessed May 21, 2 012.
6. Chesson HW, Sternberg M, Leichliter JS, Aral SO. The distribution of chlamydia, gonorrhoea and syphilis cases across states and counties in the USA, 2007. Sex Transm Infect. 2010;86(suppl 3):iii52-iii57.
7. Centers for Disease Control and Prevention. 2009 Sexually transmitted diseases surveillance. Chlamydia. http://www.cdc.gov/std/stats09/chlamydia.htm. Accessed March 6, 2011.
8. Mangione-Smith R, O'Leary J, McGlynn EA. Health and cost-benefts of chlamydia screening in young women. Sex Transm Dis. 1999;26(6): 309-316.
9. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004;291(18):2229-2236.
10. Schillinger JA, Dunne EF, Chapin JB, et al. Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities. Sex Transm Dis. 2005;32(2):74-77.
11. Annan NT, Sullivan AK, Nori A, et al. Rectal chlamydia-a reservoir of undiagnosed infection in men who have sex with men. Sex Transm Infect. 2009; 85 (3):176-179.
12. Stamm WE, Holmes K. Chlamydia trachomatis infections of the adult. In: Holmes KK, Mardh PA, Sparling PF, et al., eds. Sexually Transmitted Diseases. 2nd ed. New York, NY: McGraw-Hill; 1990:181-193.
13. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med. 2005;142(11):914-925.
14. van Dommelen L, van Tiel FH, Ouburg S, et al. Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Sex Transm Infect. 2010;86(5):355-359.
15. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29(9):497-502.
16. Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2007;30 (3):213-221.
17. Carter JD, Hudson AP. The evolving story of chlamydia-induced reactive arthritis. Curr Opin Rheumatol. 2010;22(4):424-430.
18. Carter JD, Espinoza LR, Inman RD, et al. Combination antibiotics as a treatment for chronic chlamydia-induced reactive arthritis: a doubleblind, placebo-controlled, prospective trial. Arthritis Rheum. 2010; 62 (5):1298-1307.
19. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis. 2005;16(4):235-244.
20. Gilbert DN, Moellering RC, Eliopoulos GM. The Sanford Guide to Antimicrobial Therapy 2010. 40th ed. Sperryville, Va.: Antimicrobial Therapy; 2010.
21. Katusic D, Petricek I, Mandic Z, et al. Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis. Am J Ophthalmol. 2003; 135(4):447-451.
22. Mabey D, Fraser-Hurt N, Powell C. Antibiotics for trachoma. Cochrane Database Syst Rev. 2005;(2):CD001860.
23. Centers for Disease Control and Prevention. Expedited partner therapy in the management of sexually transmitted diseases. Atlanta, Ga.: U.S. Department of Health and Human Services; 2006. http://www.cdc.gov/std/treatment/eptfnalreport2006.pdf. Accessed March 21, 2012.
24. U.S. Preventive Services Task Force. Screening for chlamydia infection: recommendation statement. Ann Intern Med. 2007;147(2):128-134.
25. Scottish Intercollegiate Guidelines Network. Management of genital chlamydia trachomatis infection. March 2009. http://www.sign.ac.uk/guidelines/fulltext/109/index.html. Accessed November 26, 2012.
26. Gift TL, Blake DR, Gaydos CA, Marrazzo JM. The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature. Sex Transm Dis. 2008;35(11 suppl):S51-S60.
27. Blake DR, Quinn TC, Gaydos CA. Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program. Sex Transm Dis. 2008;35(1):91-101.
28. Scholes D, Heidrich FE, Yarbro P, Lindenbaum JE, Marrazzo JM. Population-based outreach for chlamydia screening in men: results from a randomized trial. Sex Transm Dis. 2007;34(11):837-839.
29. Chai SJ, Aumakhan B, Barnes M, et al. Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men. Sex Transm Dis. 2010;37(12):756-763.
30. Horner PJ, Boag F. 2006 UK national guideline for the management of genital tract infection with Chlamydia trachomatis. London (UK): British Association of Sexual Health and HIV (BASHH); 2006. http://www.bashh.org/documents/61/61.pdf. Accessed March 22, 2012.
31. Shahmanesh M, Moi H, Lassau F, Janier M; IUSTI/WHO. 2009 European guideline on the management of male non-gonococcal urethritis. Int J STD AIDS. 2009;20(7):458-464.
32. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993;7(1):95-102.
33. Safaeian M, Quint K, Schiffman M, et al. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst. 2010;102(23):1794-1804.
34. Tipple MA, Beem MO, Saxon EM. Clinical characteristics of the afebrile pneumonia associated with Chlamydia trachomatis infection in infants less than six months of age. Pediatrics. 1979;63 (2):192-197.
35. Bell TA, Stamm WE, Kuo CC, Wang SP, Holmes KK, Grayston JT. Risk of perinatal transmission of Chlamydia trachomatis by mode of delivery. J Infect. 1994;29 (2):165-169.
36. Global Network for Neglected Tropical Diseases. Trachoma interactive fact sheet. http://old.globalnetwork.org/sites/all/modules/globalnetwork/factsheetxml/disease.php?id=9. Accessed February 6, 2011.
37. Rabiu M, Alhassan MB, Ejere H. Environmental sanitary interventions for preventing active trachoma. Cochrane Database Syst Rev. 2007;(4):CD004003.
38. Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med. 2004; 351(19):1962-1971.